Letter: reduction in projected mortality or need for liver transplantation associated with bezafibrate add-on in primary biliary cholangitis with incomplete UDCA response

被引：8

作者：

Corpechot, Christophe ^{[1
,2
]}

Chazouilleres, Olivier ^{[1
,2
]}

Lemoinne, Sara ^{[1
,2
]}

Rousseau, Alexandra ^{[3
]}

机构：

[1] St Antoine Hosp, AP HP, Reference Ctr Inflammatory Biliary Dis & Autoimmu, Paris, France

[2] Sorbonne Univ, INSERM, UMR S938, Paris, France

[3] St Antoine Hosp, AP HP, Clin Res Platform East Paris, Paris, France

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2019年 / 49卷 / 02期

关键词：

HIGH-RISK PBC; EDITORIAL FENOFIBRATE; 2ND-LINE THERAPY; ANSWERS;

D O I：

10.1111/apt.15049

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Linked Content This article is linked to Jones and Hansen, Cheung et al and Cheung et al papers. To view these articles, visit , and .

引用

页码：236 / 238

页数：3

共 6 条

[1] The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis [J].

Carbone, Marco ;

Sharp, Stephen J. ;

Flack, Steve ;

Paximadas, Dimitrios ;

Spiess, Kelly ;

Adgey, Carolyn ;

Griffiths, Laura ;

Lim, Reyna ;

Trembling, Paul ;

Williamson, Kate ;

Wareham, Nick J. ;

Aldersley, Mark ;

Bathgate, Andrew ;

Burroughs, Andrew K. ;

Heneghan, Michael A. ;

Neuberger, James M. ;

Thorburn, Douglas ;

Hirschfield, Gideon M. ;

Cordell, Heather J. ;

Alexander, Graeme J. ;

Jones, David E. J. ;

Sandford, Richard N. ;

Mells, George F. .

HEPATOLOGY, 2016, 63 (03) :930-950

[2] Editorial: fenofibrate as second-line therapy in high risk PBC - more answers or more questions? Authors' reply [J].

Cheung, A. C. ;

Kowgier, M. ;

Feld, J. J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (05) :649-650

[3] Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes [J].

Cheung, A. C. ;

Lapointe-Shaw, L. ;

Kowgier, M. ;

Meza-Cardona, J. ;

Hirschfield, G. M. ;

Janssen, H. L. A. ;

Feld, J. J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (02) :283-293

[4] A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis [J].

Corpechot, C. ;

Chazouilleres, O. ;

Rousseau, A. ;

Le Gruyer, A. ;

Habersetzer, F. ;

Mathurin, P. ;

Goria, O. ;

Potier, P. ;

Minello, A. ;

Silvain, C. ;

Abergel, A. ;

Debette-Gratien, M. ;

Larrey, D. ;

Roux, O. ;

Bronowicki, J. -P. ;

Boursier, J. ;

de Ledinghen, V. ;

Heurgue-Berlot, A. ;

Nguyen-Khac, E. ;

Zoulim, F. ;

Ollivier-Hourmand, I. ;

Zarski, J. -P. ;

Nkontchou, G. ;

Lemoinne, S. ;

Humbert, L. ;

Rainteau, D. ;

Lefevre, G. ;

de Chaisemartin, L. ;

Chollet-Martin, S. ;

Gaouar, F. ;

Admane, F. -H. ;

Simon, T. ;

Poupon, R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (23) :2171-2181

[5] Editorial: fenofibrate as second-line therapy in high risk PBC - more answers or more questions? [J].

Jones, D. E. J. ;

Hansen, B. E. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (05) :648-649

[6] Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy [J].

Lammers, Willem J. ;

Hirschfield, Gideon M. ;

Corpechot, Christophe ;

Nevens, Frederik ;

Lindor, Keith D. ;

Janssen, Harry L. A. ;

Floreani, Annarosa ;

Ponsioen, Cyriel Y. ;

Mayo, Marlyn J. ;

Invernizzi, Pietro ;

Battezzati, Pier M. ;

Pares, Albert ;

Burroughs, Andrew K. ;

Mason, Andrew L. ;

Kowdley, Kris V. ;

Kumagi, Teru ;

Harms, Maren H. ;

Trivedi, Palak J. ;

Poupon, Raoul ;

Cheung, Angela ;

Lleo, Ana ;

Caballeria, Llorenc ;

Hansen, Bettina E. ;

van Buuren, Henk R. .

GASTROENTEROLOGY, 2015, 149 (07) :1804-+

← 1 →